Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-β2

European Journal of Neuroscience

Volumn 11, Issue 7, 1999, Pages 2367-2374

  Logan, A ^a   Green, J ^a   Hunter, A ^a   Jackson, R ^a   Berry, M ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Central nervous system; Fibrosis; Fibrotic neuropathology; Immunoneutralization; Transforming growth factor

Indexed keywords

FIBRONECTIN; HUMAN MONOCLONAL ANTIBODY; LAMININ; PROTEOCHONDROITIN SULFATE; TRANSFORMING GROWTH FACTOR BETA2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BACILLUS PHAGE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CONNECTIVE TISSUE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROGENESIS; FIBROSIS; GLIA; HUMAN; INFLAMMATION; MACROPHAGE; MEMBRANE; MICROGLIA; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; SCAR FORMATION;

EID: 0033046894     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00654.x     Document Type: Article

References (36)

1. Adair, J.R. & Bright, S.M. 1995 Progress with humanized antibodies – an update. Exp. Opin. Invest. Drugs, 4, 863 870.
2. Baghdassarian‐Chalaye, D., Toru‐Delbauffe, D., Gaveret, J.M., Pierre, M. 1993 Effects of transforming growth factor β1 on the extracellular matrix and cytoskeleton of cultured astrocytes. Glia, 7, 193 202.
3. Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C.C., Dantis, L., Sklarin, N.T., Seidman, A.D., Hudis, C.A., Moore, J., Rosen, P.P., Twaddell, T., Henderson, I.C., Norton, L. 1996 Phase II study of weekly intravenous recombinant humanized anti‐p185HER2 monoclonal antibody in patients with HER2/neu‐overexpressing metastatic breast cancer. J. Clin. Oncol., 14, 737 744.
4. Crowe, J.E., Murphy, B.R., Chanock, R.M., Williamson, R.A., Barbas, C.F. III, Burton, D.R. 1994 Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV‐infected mice. Proc. Natl Acad. Sci. USA, 91, 1386 1390.
5. Cui, W. & Ackhurst, R.J. 1996 Transforming growth factor βs: Biochemistry and biological activities in vivo and in vitro. In LeRoith, D. & Bondy, C, eds. Growth Factors in Health and Disease. JAI Press, Greenwich, Connecticut, pp. 319 356.
6. Flanders, K., Ludecke, G., Renzing, J., Hamm, C., Cissel, D., Unsicker, K. 1993 Effects of TGFβs and bFGF on astroglial cell growth and gene expression in vitro. Mol. Cell. Neurosci., 4, 406 417.
7. Gagelin, C., Pierre, M., Gaveret, J.‐M., Toru‐Delbauffe, D. 1995 Rapid TGFβ1 effects on actin cytoskeleton of astrocytes: comparison with other factors and implications for cell motility. Glia, 13, 283 293.
8. Griffiths, A.D., Malmqvist, M., Marks, J.D., Bye, J.M., Embleton, M.J., McCafferty, J., Baier, M., Holliger, K.P., Gorick, B.D., Hughes‐Jones, N.C. 1993 Human anti‐self antibodies with high specificity from phage display libraries. EMBO J., 12, 725 734.
9. Heino, J. & Massague, J. 1989 Transforming growth factor β switches the pattern of integrins expressed in MG‐63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J. Biol. Chem., 36, 21 806 21 811.
10. Hurwitz, A., Lyman, W., Berman, J. 1995 Tumour necrosis factor alpha and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein – 1. J. Neuroimmunol., 57, 193 198.
11. Ignotz, R.A., Heino, J., Massague, J. 1989 Regulation of cell adhesion receptors by transforming growth factor β. Regulation of vitronectin receptor and LFA‐1. J. Biol. Chem., 264, 389 392.
12. Ignotz, R.A. & Massague, J. 1989 Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem, 261, 4337 4345.
13. Jackson, H., Bacon, L., Pedley, B., Derbyshire, E., Field, A., Osbourn, J., Allen, D. 1998 Antigen specificity and tumour targeting efficiency of a human CEA specific scFv and affinity matured derivatives. Brit. J. Cancer., in press.
14. Kerr, L.D., Miller, D.B., Matrisian, L.M. 1990 TGFβ1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell, 61, 267 278.
15. Kitazawa, K. & Tada, T. 1994 Elevation of transforming growth factor‐β in cerebrospinal fluid of patients with communicating hydrocephalus after sub‐arachnoid haemorrhage. Stroke, 25, 1400 1404.
16. Krupinski, J., Kumar, P., Kumar, S., Kaluza, J. 1996 Increased expression of TGF‐β in brain tissue after ischemic stroke in humans. Stroke, 27, 852 857.
17. Labourdette, G., Thiery, J., Laeng, P., Perraud, F., Lawrence, D., Pettman, B. 1990 Transforming growth factor β1 modulates the effects of basic fibroblast growth factor on growth and phenotypic expression of rat astroblasts in vitro. J. Cell Biol., 144, 473 484.
18. Laiho, M., Saksela, O., Andreasen, P.A., Keski‐Oja, J. 1986 Enhanced production and extracellular deposition of the endothelial‐type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor β. J. Cell Biol., 103, 2403 2410.
19. Logan, A. & Berry, M. 1994 Cellular response of central nervous system tissue to invasive therapeutic measures. Meth. Neurosci., 21, 3 19.
20. Logan, A., Berry, M., Gonzalez, A.M., Frautschy, S.A., Sporn, M.B., Baird, A. 1994 Effects of transforming growth factor β1 on scar production in the injured central nervous system. Eur. J. Neurosci., 6, 355 363.
21. Logan, A., Frautschy, S.A., Gonzalez, A.M., Sporn, M.B., Baird, A. 1992 Enhanced expression of transforming growth factor β1 in the rat brain after a localised cerebral injury. Brain Res., 587, 216 225.
22. Lucas, C., Fendly, B.M., Mukku, V.R., Wong, W.L., Palladino, M.A. 1991 Generation of antibodies and assays for transforming growth factor β. Meth. Enzymol., 198, 303 316.
23. Lund, L.R., Riccio, A., Andreasen, P.A., Nielsen, L.S., Kristensen, P., Laiho, M., Saksela, O., Blasi, F., Dano, K. 1987 Transforming growth factor‐β is a strong and fast acting positive regulator of the level of type‐1 plasminogen activator‐inhibitor mRNA in WI‐38 human lung fibroblasts. EMBO J., 6, 1281 1286.
24. Marks, J.D., Hoogenboom, H.R., Bonnert, T.P., McCafferty, J., Griffiths, A.D., Winter, G. 1991 By‐passing immunization: Human antibodies from V‐gene libraries displayed on phage. J. Mol. Biol., 222, 581 597.
25. Neri, D., Carnemolla, B., Nissim, A., Leprini, A., Querze, G., Balza, E., Pini, L., Tarli, A., Halin, C., Neri, P., Zardi, L., Winter, G. 1997 Targeting by affinity‐matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nature Biotech., 15, 1271 1275.
26. Pepper, M.S. 1997 Transforming growth factor‐β: Vasculogenesis, angiogenesis and vessel wall integrity. Cytokine Growth Factor Rev., 8, 21 43.
27. Pratt, B.M. & McPherson, J.M. 1997 TGF‐βs in the central nervous system: Potential roles in ischaemic injury and neurodegenerative diseases. Cytokine Growth Factor Rev., 8, 267 292.
28. Randall, L.A., Wadhwa, M., Thorpe, R., Mire‐Sluis, A.R. 1993 A novel, sensitive bioassay for transforming growth factor β. J. Immunol. Meth., 164, 61 67.
29. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga, V., Kehrl, J.H., Fauci, A.S. 1986 Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen synthesis in vitro. Proc. Natl Acad. Sci. USA, 83, 4167 4171.
30. Thompson, J.E., Vaughan, T.J., Williams, A.J., Wilton, J., Johnson, K.S., Bacon, L., Green, J.A., Field, R., Ruddock, S., Martins, M., Pope, A.R., Tempest, P.R., Jackson, R.H. 1999 A fully human antibody neutralising biologically active human TGFβ2 for use in therapy. J. Immunol. Meth., in press.
31. Toru‐Delbauffe, D., Baghdassarian‐Chalaye, D., Gaveret, J.M., Courtin, F., Pomerance, M., Pierre, M. 1990 Effects of transforming growth factor β1 on astroglial cells in culture. J. Neurochem., 54, 1056 1061.
32. Varga, J., Rosenbloom, J., Jimenez, S.A. 1987 Transforming growth factor beta causes a persistent increase in steady‐state amounts for type I and type III collagen and fibronectin mRNAs in normal dermal human fibroblasts. Biochem. J., 297, 597 604.
33. Vaughan, T.J., Williams, A.J., Pritchard, K., Osbourn, J.K., Pope, A.R., Earnshaw, J.C., McCafferty, J., Hodits, R.A., Wilton, J., Johnson, K.S. 1996 Human antibodies with sub‐nanomolar affinities isolated from a large non‐immunized phage display library. Nature Biotech., 14, 309 314.
34. Wahl, S.M., Hunt, D.A., Wakefield, L.M., McCartney‐Francis, N., Wahl, L.M., Roberts, A.B., Sporn, M.B. 1987 Transforming growth factor β induces monocyte chemotaxis and growth factor production. Proc. Natl Acad. Sci. USA, 84, 5788 5792.
35. Wrana, J.L., Sodek, J., Ber, R.L., Bellows, C.G. 1986 The effects of platelet‐derived transforming growth factor‐β on normal diploid gingival fibroblasts. Eur. J. Biochem., 159, 69 76.
36. Wyss‐Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson‐Wood, K., Lin, C., Mucke, L. 1997 Amyloidogenic role of cytokine TGF‐β1 in transgenic mice and in Alzheimer’s disease. Nature, 389, 603 606.